Showcasing our Organiser's Choice Innovations at HKU Innovation Week cum Award Ceremony

We are thrilled to announce that our groundbreaking targeted radionuclide administrative platform, designed for optimized treatment efficiency and the absence of side effects, has been awarded both the Gold Medal and the Organizer's Choice at the International Invention Innovation Competition (iCAN) 2025 in Canada. This prestigious event, recognized globally as a premier platform for inventors, highlights innovations that address critical challenges in various fields.

Our team showcased this cutting-edge invention during the HKU Innovation Week cum Award Ceremony, attracting attention from prominent investors and leaders in the region. Among the distinguished attendees was Mr. Peter YAN King-shun, JP, Director-General of the Office for Attracting Strategic Enterprises, The Government of the Hong Kong Special Administrative Region of the People’s Republic of China. His presence underscored the significance of our innovation within the broader context of strategic enterprise development.

We extend our heartfelt gratitude to everyone who has supported us throughout this journey. Your encouragement and collaboration have been invaluable as we strive to revolutionize the healthcare landscape.

OASES Director-General Mr Peter Yan, JP visited and listened to introduction of our innovative targeted radionuclide administrative platform for cancer treatment by L'Ord'invent Limited Managing Director Prof Victor Lee in HKU Innovation Week cum Award Ceremony.

L'Ord'invent Limited Managing Director Prof Victor Lee has been awarded Gold Medal and Organizer's Choice in iCAN 2025.